Gavin Jones
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gavin Jones has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Eric C. Ko
UMass Chan Medical School
3 shared publications - Brett Diamond
UMass Chan Medical School
2 shared publications - Christopher Utkarsh
UMass Chan Medical School
2 shared publications - Jessica Yancey
UMass Chan Medical School
2 shared publications - Mark Sueyoshi
UMass Chan Medical School
2 shared publications - Thomas J. FitzGerald
UMass Chan Medical School
2 shared publications
Latest Publications
- 1 October 2025
- Published by Springer Nature
- p. 529-543
Immunology and Radiation Therapy
- Open Access
- 22 July 2024
- Published by IntechOpen
Radiation Therapy for Medulloblastoma
Radiation therapy remains a cornerstone in the clinical care of patients with medulloblastoma. Nevertheless, while treatment with radiation improves disease control, it is also associated with potential late effects impacting neurologic and neurocognitive function, pituitary function as well as hearing. The development of secondary, treatment-related malignancies is an uncommon but possible late outcome. In this chapter, we review the role of radiation therapy in medulloblastoma, as well as changes in management that have resulted both from technological therapeutic advancements and enterprising cooperative group clinical trials for this disease. Moreover, with increasing utilization of molecular diagnostics both for prognosis and stratification of treatment, we also endeavor to explore opportunities to further improve the delivery of radiation therapy to patients with varied risk of disease recurrence.
- 22 July 2024
- Published by IntechOpen
Open AccessRadiation Therapy for Medulloblastoma
Radiation therapy remains a cornerstone in the clinical care of patients with medulloblastoma. Nevertheless, while treatment with radiation improves disease control, it is also associated with potential late effects impacting neurologic and neurocognitive function, pituitary function as well as hearing. The development of secondary, treatment-related malignancies is an uncommon but possible late outcome. In this chapter, we review the role of radiation therapy in medulloblastoma, as well as changes in management that have resulted both from technological therapeutic advancements and enterprising cooperative group clinical trials for this disease. Moreover, with increasing utilization of molecular diagnostics both for prognosis and stratification of treatment, we also endeavor to explore opportunities to further improve the delivery of radiation therapy to patients with varied risk of disease recurrence.
- 1 January 2022
- Published by Springer Nature
- p. 1-15
Immunology and Radiation Therapy